Repaglinide
Who holds supplier records for Repaglinide? 13 organisations hold a current record for Repaglinide: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), China (2), Germany (1) and Iceland (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Repaglinide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/repaglinide
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
9 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Repaglinide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 23068 · latest filing Aug 2009
- Biocon LimitedIndiaCEPActive DMF 18482 · latest filing Jul 2005
- BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 19620 · latest filing Jul 2006
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 26396 · latest filing Sept 2012
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 17245 · latest filing Mar 2004
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 24519 · latest filing Mar 2011
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 22234 · latest filing Nov 2008
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 17825 · latest filing Nov 2004
- Torrent PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 25663 · latest filing Jan 2012
- USV PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 18329 · latest filing May 2005
- TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTDChinaActive DMF 29922 · latest filing Oct 2015
- IcelandCEP Company GMP cert on record
- Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (12)
Certificates of Suitability on the EDQM register for Repaglinide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2011-202 - Rev 02 Repaglinide | Mar 2026 | — |
| USV PRIVATE LIMITED Mumbai | IN | CEP 2009-239 - Rev 03 Repaglinide, Form I | Aug 2025 | — |
| BIOCON LIMITED Bengaluru | IN | CEP 2008-093 - Rev 02 Repaglinide | Dec 2024 | — |
| ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2008-201 - Rev 06 Repaglinide | Apr 2024 | Inspected Jan 2024 Germany |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2008-044 - Rev 02 Repaglinide | Jan 2024 | — |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | R1-CEP 2012-087 - Rev 00 Repaglinide | Sept 2018 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2008-196 - Rev 03 Repaglinide | Jun 2018 | — |
| Torrent Pharmaceuticals Limited Ahmedabad | IN | R1-CEP 2011-308 - Rev 00 Repaglinide | Aug 2017 | — |
| ACTAVIS GROUP PTC EHF Hafnarfjordur | IS | R1-CEP 2010-304 - Rev 01 Repaglinide | Feb 2017 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2009-375 - Rev 01 Repaglinide | Jan 2016 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | R1-CEP 2006-069 - Rev 02 Repaglinide | May 2015 | — |
| BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am Rhein | DE | R1-CEP 2006-123 - Rev 00 Repaglinide | Sept 2012 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Repaglinide are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- China · Inactive DMF 28838 · filed Nov 2014
- Poland · Inactive DMF 21149 · filed Dec 2007
- China · Inactive DMF 20999 · filed Oct 2007
- RANBAXY LABORATORIES LTDInactive DMF 19010 · filed Dec 2005
- France · Inactive DMF 18003 · filed Jan 2005
Overview
Repaglinide is an oral medication used to manage Type 2 diabetes mellitus by stimulating the release of insulin from pancreatic beta cells. It is classified as a meglitinide and helps control blood sugar levels post-prandially.
Chemical identity
- IUPAC name
- 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid
- Canonical SMILES
- CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
- InChIKey
- FAEKWTJYAYMJKF-QHCPKHFHSA-N
- Synonyms
- Prandin API, a10bx02, ag-ee 623 zw, ag-ee-623-zw, ag-ee-623zw, agee-623zw, nsc-759893, prandin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Glinide
- Mechanism of action
- Potassium Channel Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Repaglinide?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Repaglinide: APITORIA PHARMA PRIVATE LTD (India), Biocon Limited (India), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (Germany), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), JUBILANT BIOSYS LTD (India), Macleods Pharmaceuticals Ltd. (India) and Sun Pharmaceutical Industries Limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Repaglinide Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 23068), Biocon Limited (DMF 18482), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (DMF 19620), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 26396), Dr. Reddy's Laboratories Ltd. (DMF 17245), JUBILANT BIOSYS LTD (DMF 24519), Macleods Pharmaceuticals Ltd. (DMF 22234) and Sun Pharmaceutical Industries Limited (DMF 17825) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Repaglinide records mean?
5 organisations have only inactive Type II DMFs for Repaglinide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Repaglinide have a European Certificate of Suitability?
Yes. 12 organisations hold a valid CEP for Repaglinide on the EDQM register, including JUBILANT BIOSYS LIMITED Mysuru (IN), USV PRIVATE LIMITED Mumbai (IN), BIOCON LIMITED Bengaluru (IN), ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City (CN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN) and 6 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Repaglinide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Repaglinide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.